Key facts
- This page summarizes Braslyn Ltd.'s Form 3 filing for Tango Therapeutics, Inc. (TNGX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Jan 2022, 16:00.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
These securities are owned directly by Braslyn Ltd. ("Braslyn"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc. ("Boxer Management"), (iv) Joseph C. Lewis, (v) BCTG Holdings, LLC, (vi) MVA Investors, LLC and (vii) Aaron I. Davis (collectively, the "Boxer Group"), and indirectly by Joseph C. Lewis who is the sole indirect beneficial owner of and controls Braslyn. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.